Newsbenzinga
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…